SEC 13F Intelligence

Rtw Investments, LP / APGE

Rtw Investments, LP’s Apogee Therapeutics Inc Position

Does Rtw Investments, LP own Apogee Therapeutics Inc (APGE)? Yes — 2.78M shares worth $234M (+2.33% of its 13F portfolio) as of Q1 2026, up from 2.71M shares the prior filed quarter.

Position Value
$234M
Q1 2026
Shares
2.78M
% of Portfolio
+2.33%
Quarters Held
11
currently held

Position History APGE

Reported value by quarter
Q3 ’23: $46MQ3 ’23Q4 ’23: $60MQ1 ’24: $164MQ1 ’24Q2 ’24: $107MQ3 ’24: $159MQ3 ’24Q4 ’24: $123MQ1 ’25: $101MQ1 ’25Q2 ’25: $118MQ3 ’25: $108MQ3 ’25Q4 ’25: $205MQ1 ’26: $234MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.78M$234M+2.33%
Q4 20252.71M$205M+2.05%
Q3 20252.71M$108M+1.33%
Q2 20252.71M$118M+1.68%
Q1 20252.71M$101M+1.55%
Q4 20242.71M$123M+1.86%
Q3 20242.71M$159M+2.31%
Q2 20242.71M$107M+1.65%
Q1 20242.47M$164M+2.42%
Q4 20232.14M$60M+0.94%
Q3 20232.14M$46M+0.96%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of APGE.